Holen Sie sich die Stockscreener-App
2.65
4.68%
-0.13
Handel nachbörslich:
2.61
-0.04
-1.51%
Schlusskurs vom Vortag:
$2.78
Offen:
$2.78
24-Stunden-Volumen:
709.99K
Relative Volume:
1.00
Marktkapitalisierung:
$186.49M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.7667
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-10.47%
1M Leistung:
-18.71%
6M Leistung:
-30.81%
1J Leistung:
-66.24%
1-Tages-Spanne:
$2.61
$2.81
1-Wochen-Bereich:
$2.61
$3.0399
52-Wochen-Spanne:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.65 | 195.64M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Upland Software, Health Catalyst, SoundHound AI, BILL, and DigitalOcean Stocks Trade Down, What You Need To Know - Yahoo Finance
How moving averages guide Health Catalyst Inc. tradingStock Surge & Breakout Confirmation Trade Signals - newser.com
Can you recover from losses in Health Catalyst Inc.2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Should I hold or sell Health Catalyst Inc. stock in 2025Portfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Does Health Catalyst Inc. (2YP) stock trade below intrinsic valuePortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Will Health Catalyst Inc. (2YP) stock keep high P E multiplesTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Will breakout in Health Catalyst Inc. lead to full recoveryTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com
Is Health Catalyst Inc. stock ready for a breakoutWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Should you wait for a breakout in Health Catalyst Inc.2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Best data tools to analyze Health Catalyst Inc. stock2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - newser.com
Best Places to Work 2025 - Modern Healthcare
What moving averages say about Health Catalyst Inc.Weekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Health Catalyst Inc. (2YP) stock protected from inflationWeekly Investment Summary & Consistent Income Trade Ideas - newser.com
Keybanc Lowers Price Target for Health Catalyst (HCAT) | HCAT St - GuruFocus
HCAT: Evercore ISI Group Lowers Price Target for Health Catalyst - GuruFocus
Population Health Management Market Size, Potential Scope 2032 - openPR.com
Health Catalyst, Upstart, ON24, Semrush, and Flywire Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst (HCAT) Receives Neutral Rating from Cantor Fitzg - GuruFocus
How to integrate Health Catalyst Inc. into portfolio analysis toolsInflation Watch & Real-Time Buy Signal Alerts - newser.com
Historical volatility pattern of Health Catalyst Inc. visualizedPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
What analysts say about Health Catalyst Inc stockReal Estate Investment Trusts & Superior Capital Investment - earlytimes.in
News impact scoring models applied to Health Catalyst Inc.2025 Year in Review & Proven Capital Preservation Tips - newser.com
Intraday pattern recognizer results for Health Catalyst Inc.July 2025 Momentum & Weekly Market Pulse Alerts - newser.com
What analysts say about Health Catalyst Inc 2YP stockResistance Zone Identification & Small Budget Big Profits - Early Times
What drives Health Catalyst Inc stock priceEarnings Revision Updates & Low Risk Trading Plans - earlytimes.in
Healthcare Tech Veteran with 25-Year Track Record: Healthmine Taps VillageMD's Erskine as New CEO - Stock Titan
Health Catalyst appoints Ben Albert as President and COO - MSN
Signal Advisors Wealth LLC Invests $645,000 in Health Catalyst, Inc. $HCAT - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Hedge Fund Moves: Is Health Catalyst Inc. forming higher highs and higher lowsOil Prices & Stepwise Swing Trade Plans - khodrobank.com
Acadian Asset Management LLC Has $4.21 Million Holdings in Health Catalyst, Inc. $HCAT - MarketBeat
Returns Recap: Is Health Catalyst Inc. stock heavily shortedJuly 2025 Rallies & Reliable Entry Point Trade Alerts - khodrobank.com
Health Catalyst, Twilio, Palantir Technologies, Zscaler, and Appian Shares Skyrocket, What You Need To Know - TradingView
Aug Reactions: Is Health Catalyst Inc a top pick in the sectorQuarterly Market Summary & Reliable Price Breakout Alerts - خودرو بانک
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.35%
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):